Skip to main content
. 2015 Sep 11;5:13982. doi: 10.1038/srep13982

Figure 1. DGLHD treatment delayed the onset and development of diabetes.

Figure 1

(A) OGTT of NOD mice treated with DGLHD for 4 weeks from 8 until 12 weeks of age or model control animals (n = 6). (B) ITT of NOD mice treated with DGLHD or model control animals (n = 6). (C) Effect of DGLHD on the serum insulin secretion (n = 3). (D) Effect of DGLHD and ingredients on the insulin secretion in NIT-1 supernatant (n = 3). (E) Effect of DGLHD and the active ingredients on the glucose uptake of HepG2 (n = 3). (F) Diabetes incidence in NOD mice at 26 weeks of age treated with or without DGLHD (n = 8). Data were presented as means ± SD. *P < 0.05, **P < 0.01 compared with model control/control group. #P < 0.05, ##P < 0.01 compared with DGLHD group.